454 related articles for article (PubMed ID: 18534710)
1. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.
Larter CZ; Yeh MM; Williams J; Bell-Anderson KS; Farrell GC
J Hepatol; 2008 Sep; 49(3):407-16. PubMed ID: 18534710
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
Koppe SW; Sahai A; Malladi P; Whitington PF; Green RM
J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
[TBL] [Abstract][Full Text] [Related]
3. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
[TBL] [Abstract][Full Text] [Related]
5. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
Kirsch R; Clarkson V; Verdonk RC; Marais AD; Shephard EG; Ryffel B; de la M Hall P
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830
[TBL] [Abstract][Full Text] [Related]
6. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice.
McCuskey RS; Ito Y; Robertson GR; McCuskey MK; Perry M; Farrell GC
Hepatology; 2004 Aug; 40(2):386-93. PubMed ID: 15368443
[TBL] [Abstract][Full Text] [Related]
7. Quantitative trait loci analysis of mice administered the methionine-choline deficient dietary model of experimental steatohepatitis.
Rangnekar AS; Lammert F; Igolnikov A; Green RM
Liver Int; 2006 Oct; 26(8):1000-5. PubMed ID: 16953841
[TBL] [Abstract][Full Text] [Related]
8. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice.
Leclercq IA; Farrell GC; Sempoux C; dela Peña A; Horsmans Y
J Hepatol; 2004 Dec; 41(6):926-34. PubMed ID: 15582125
[TBL] [Abstract][Full Text] [Related]
9. NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis.
dela Peña A; Leclercq IA; Williams J; Farrell GC
J Hepatol; 2007 Feb; 46(2):304-13. PubMed ID: 17157947
[TBL] [Abstract][Full Text] [Related]
10. Effects of iron overload in a rat nutritional model of non-alcoholic fatty liver disease.
Kirsch R; Sijtsema HP; Tlali M; Marais AD; Hall Pde L
Liver Int; 2006 Dec; 26(10):1258-67. PubMed ID: 17105592
[TBL] [Abstract][Full Text] [Related]
11. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
[TBL] [Abstract][Full Text] [Related]
13. Roles of phosphatidylinositol 3-kinase and osteopontin in steatosis and aminotransferase release by hepatocytes treated with methionine-choline-deficient medium.
Sahai A; Pan X; Paul R; Malladi P; Kohli R; Whitington PF
Am J Physiol Gastrointest Liver Physiol; 2006 Jul; 291(1):G55-62. PubMed ID: 16439472
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
[TBL] [Abstract][Full Text] [Related]
15. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator.
Yu J; Ip E; Dela Peña A; Hou JY; Sesha J; Pera N; Hall P; Kirsch R; Leclercq I; Farrell GC
Hepatology; 2006 Apr; 43(4):826-36. PubMed ID: 16557554
[TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice.
Nan YM; Fu N; Wu WJ; Liang BL; Wang RQ; Zhao SX; Zhao JM; Yu J
Scand J Gastroenterol; 2009; 44(3):358-65. PubMed ID: 18991162
[TBL] [Abstract][Full Text] [Related]
17. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
[TBL] [Abstract][Full Text] [Related]
18. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.
Min AK; Kim MK; Kim HS; Seo HY; Lee KU; Kim JG; Park KG; Lee IK
Life Sci; 2012 Jan; 90(5-6):200-5. PubMed ID: 22154902
[TBL] [Abstract][Full Text] [Related]
19. [The role of apoptosis and the related genes in non-alcoholic steatohepatitis].
Nan YM; Wu WJ; Yao XX; Wang L
Zhonghua Gan Zang Bing Za Zhi; 2007 Jan; 15(1):41-6. PubMed ID: 17244458
[TBL] [Abstract][Full Text] [Related]
20. Prevention of steatohepatitis by pioglitazone: implication of adiponectin-dependent inhibition of SREBP-1c and inflammation.
Da Silva Morais A; Lebrun V; Abarca-Quinones J; Brichard S; Hue L; Guigas B; Viollet B; Leclercq IA
J Hepatol; 2009 Mar; 50(3):489-500. PubMed ID: 19155087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]